Heart Health

|

10

Lifestyle Counseling Tied to Better Outcomes for Patients with Diabetes

Exercise. Improve your diet. Lose weight. You’ve probably heard the mantra over and over again. People living with diabetes know that along …

|

Mediterranean Diet Linked to Better Brain Function For Those with Diabetes

Following a Mediterranean diet, which includes eating plenty of fruits, vegetables, beans, and good fats, may improve brain function, according to a …

| |

Mount Sinai Researchers: Diabetes Drug May Reverse Heart Failure

Researchers have demonstrated that the recently developed antidiabetic drug empagliflozin can treat and reverse the progression of heart failure in …

|

Diabetic Drug Shown to Reduce the Risk of Heart Disease in Non-diabetic Patients

The commonly used diabetes drug metformin could reverse the harmful thickening of the heart muscle that leads to cardiovascular disease, according to …

|

Study Explaining Side Effects of Statins Finds Drug Can Have Unexpected Benefits

While investigating why cholesterol-lowering drugs called statins cause negative side effects such as blurred vision, short-term memory loss or …

|

AstraZeneca’s Drug Successful in Patients with Coronary Artery Disease and Type 2 Diabetes

AstraZeneca’s drug Brilinta® met primary endpoints in Phase 3 trials, the company reported on Monday. The trials showed that Brilinta …

| |

Two Type 2 Diabetes Drugs Linked to Higher Risk of Heart Disease

Two drugs commonly prescribed to treat type 2 diabetes carry a high risk of cardiovascular events such as heart attack, stroke, heart failure or …

|

Diabetes Drug Could be Used to Treat Common Heart Problem, Study Suggests

Researchers at the University of Arizona have discovered that metformin, a drug commonly used to treat type 2 diabetes, might also be used to treat …

| |

Genetic Analyses Hone Risk Prediction for Coronary Artery Disease

Assessing factors that boost the risk of major coronary artery disease can help to improve risk assessments for those with Type 2 diabetes, but new …

|